MICHELLE QUINN: Open Payments
NPI 1952332231 · PALO ALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 21 payments from 12 companies in 2025. Trend: 2023 $290 · 2024 $241 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $148 |
| Organon LLC | 2 | $62 |
| Biofrontera Inc. | 2 | $59 |
| ABBVIE INC. | 2 | $55 |
| PFIZER INC. | 2 | $54 |
| REVANCE THERAPEUTICS, INC. | 1 | $32 |
| LEO Pharma Inc. | 1 | $29 |
| Arcutis Biotherapeutics, Inc. | 1 | $29 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $27 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $25 |
Products named: LIBTAYO, VTAMA, RINVOQ, CIBINQO, DAXI, ADBRY, Zoryve, Winlevi.
Industry payments across CA — which companies pay providers there.
